Based on Eli Lilly's public statements and the typical FDA review timeline, retatrutide approval is most likely in 2027 or early 2028
Dennis Schoen | Founder + CEO [1] Sinha R, Sinha I, Calcagnotto A, et al
GLP-1s for weight loss account for more than 10% of annual prescription drug claims for employer-based plans that reimburse them, according to recent data
PHIL: I don't know
Pros Contains lutein to support eye health Gluten-free, dairy-free, soy-free Cons Dosage is 3-6 per day Thorne's multivitamin features a slew of nutrients said to be more absorbable, including calcium, magnesium, and vitamins A, B12, B6, and D said to promote good bone health, skin health, and healthy immune function
Matrix selection also changes both biological meaning and technical risk